Phase I trial with GD3-lactone-KLH conjugate and immunological adjuvant QS-21 vaccine with malignant melanoma Meeting Abstract

  

Authors:	Ragupathi, G.; Meyers, M.; Adluri, S.; Ritter, G.; Livingston, P. O.
Abstract Title:	Phase I trial with GD3-lactone-KLH conjugate and immunological adjuvant QS-21 vaccine with malignant melanoma
Meeting Title:	88th Annual Meeting of the American Association for Cancer Research
Keywords:	oncology; immunotherapy; malignant melanoma; tumor vaccine; phase i trial; patient; neoplastic disease; gd3 lactone-keyhole limpet hemocyanin conjugate; qs-21 immunological adjuvant
Journal Title:	Proceedings of the American Association for Cancer Research Annual Meeting
Volume:	38
Meeting Dates:	1997 Apr 12-16
Meeting Location:	San Diego, CA
ISSN:	0197-016X
Publisher:	American Association for Cancer Research
Date Published:	1997-03-01
Start Page:	398
Language:	English
ACCESSION:	BCI:BCI199799532071
PROVIDER:	biosis
Notes:	Meeting abstract: 2670 -- Source: Biosis

https://synapse.mskcc.org/synapse/works/has_related_data_chk/117556